PARP inhibitors for metastatic breast cancer

Share :
Published: 29 Jan 2020
Views: 957
Rating:
Save
Prof Banu Arun - MD Anderson Cancer Center, Houston, USA

Prof Banu Arun spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about PARP inhibitors for metastatic breast cancer.

She highlights some of the recent trials that have been testing PARP inhibitors in this setting.

Prof Arun finalises by suggesting how these trials may develop, particularly looking at combination of platinums.